|
1
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tan ML, Choong PF and Dass CR:
Osteosarcoma: Conventional treatment vs. Gene therapy. Cancer Biol
Ther. 8:106–117. 2009. View Article : Google Scholar
|
|
3
|
Broadhead ML, Clark JC, Myers DE, Dass CR
and Choong PF: The molecular pathogenesis of osteosarcoma: A
review. Sarcoma. 2011:9592482011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
He JP, Hao Y, Wang XL, Yang XJ, Shao JF,
Guo FJ and Feng JX: Review of the molecular pathogenesis of
osteosarcoma. Asian Pac J Cancer Prev. 15:5967–5976. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen H, Pong RC, Wang Z and Hsieh JT:
Differential regulation of the human gene DAB2IP in normal and
malignant prostatic epithelia: Cloning and characterization.
Genomics. 79:573–581. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Z, Tseng CP, Pong RC, Chen H,
McConnell JD, Navone N and Hsieh JT: The mechanism of
growth-inhibitory effect of DOC-2/DAB2 in prostate cancer.
Characterization of a novel GTPase-activating protein associated
with N-terminal domain of DOC-2/DAB2. J Biol Chem. 277:12622–12631.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang R, He X, Liu W, Lu M, Hsieh JT and
Min W: AIP1 mediates TNF-alpha-induced ASK1 activation by
facilitating dissociation of ASK1 from its inhibitor 14-3-3. J Clin
Invest. 111:1933–1943. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dote H, Toyooka S, Tsukuda K, Yano M,
Ouchida M, Doihara H, Suzuki M, Chen H, Hsieh JT, Gazdar AF and
Shimizu N: Aberrant promoter methylation in human DAB2 interactive
protein (hDAB2IP) gene in breast cancer. Clin Cancer Res.
10:2082–2089. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dote H, Toyooka S, Tsukuda K, Yano M, Ota
T, Murakami M, Naito M, Toyota M, Gazdar AF and Shimizu N: Aberrant
promoter methylation in human DAB2 interactive protein (hDAB2IP)
gene in gastrointestinal tumour. Br J Cancer. 92:1117–1125. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yano M, Toyooka S, Tsukuda K, Dote H,
Ouchida M, Hanabata T, Aoe M, Date H, Gazdar AF and Shimizu N:
Aberrant promoter methylation of human DAB2 interactive protein
(hDAB2IP) gene in lung cancers. Int J Cancer. 113:59–66. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qiu GH, Xie H, Wheelhouse N, Harrison D,
Chen GG, Salto-Tellez M, Lai P, Ross JA and Hooi SC: Differential
expression of hDAB2IPA and hDAB2IPB in normal tissues and promoter
methylation of hDAB2IPA in hepatocellular carcinoma. J Hepatol.
46:655–663. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Smits M, van Rijn S, Hulleman E, Biesmans
D, van Vuurden DG, Kool M, Haberler C, Aronica E, Vandertop WP,
Noske DP and Würdinger T: EZH2-regulated DAB2IP is a
medulloblastoma tumor suppressor and a positive marker for
survival. Clin Cancer Res. 18:4048–4058. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang X, Li N, Li X, Zhao W, Qiao Y, Liang
L and Ding Y: Low expression of DAB2IP contributes to malignant
development and poor prognosis in hepatocellular carcinoma. J
Gastroenterol Hepatol. 27:1117–1125. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Duan YF, Li DF, Liu YH, Mei P, Qin YX, Li
LF, Lin QX and Li ZJ: Decreased expression of DAB2IP in pancreatic
cancer with wild-type KRAS. Hepatobiliary Pancreat Dis Int.
12:204–209. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shen YJ, Kong ZL, Wan FN, Wang HK, Bian
XJ, Gan HL, Wang CF and Ye DW: Downregulation of DAB2IP results in
cell proliferation and invasion and contributes to unfavorable
outcomes in bladder cancer. Cancer Sci. 105:704–712. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Min J, Liu L, Li X, Jiang J, Wang J, Zhang
B, Cao D, Yu D, Tao D, Hu J, et al: Absence of DAB2IP promotes
cancer stem cell like signatures and indicates poor survival
outcome in colorectal cancer. Sci Rep. 5:165782015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Min W, Lin Y, Tang S, Yu L, Zhang H, Wan
T, Luhn T, Fu H and Chen H: AIP1 recruits phosphatase PP2A to ASK1
in tumor necrosis factor-induced ASK1-JNK activation. Circ Res.
102:840–848. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xie D, Gore C, Zhou J, Pong RC, Zhang H,
Yu L, Vessella RL, Min W and Hsieh JT: DAB2IP coordinates both
PI3K-Akt and ASK1 pathways for cell survival and apoptosis. Proc
Natl Acad Sci USA. 106:19878–8383. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xie D, Gore C, Liu J, Pong RC, Mason R,
Hao G, Long M, Kabbani W, Yu L, Zhang H, et al: Role of DAB2IP in
modulating epithelial-to-mesenchymal transition and prostate cancer
metastasis. Proc Natl Acad Sci USA. 107:2485–2490. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kong Z, Xie D, Boike T, Raghavan P, Burma
S, Chen DJ, Habib AA, Chakraborty A, Hsieh JT and Saha D:
Downregulation of human DAB2IP gene expression in prostate cancer
cells results in resistance to ionizing radiation. Cancer Res.
70:2829–2839. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu K, Xie D, Zou Y, Zhang T, Pong RC, Xiao
G, Fazli L, Gleave M, He D, Boothman DA and Hsieh JT: The mechanism
of DAB2IP in chemoresistance of prostate cancer cells. Clin Cancer
Res. 19:4740–4749. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu K, Wang B, Chen Y, Zhou J, Huang J, Hui
K, Zeng J, Zhu J, Zhang K, Li L, et al: DAB2IP regulates the
chemoresistance to pirarubicin and tumor recurrence of non-muscle
invasive bladder cancer through STAT3/Twist1/P-glycoprotein
signaling. Cell Signal. 27:2515–2523. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang T, Shen Y, Chen Y, Hsieh JT and Kong
Z: The ATM inhibitor KU55933 sensitizes radioresistant bladder
cancer cells with DAB2IP gene defect. Int J Radiat Biol.
91:368–378. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang H, Zhang R, Luo Y, D'Alessio A,
Pober JS and Min W: AIP1/DAB2IP, a novel member of the Ras-GAP
family, transduces TRAF2-induced ASK1-JNK activation. J Biol Chem.
279:44955–49965. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee GH, Kim SH, Homayouni R and
D'Arcangelo G: Dab2ip regulates neuronal migration and neurite
outgrowth in the developing neocortex. PLoS One. 7:e465922012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Harrison SC, Cooper JA, Li K, Talmud PJ,
Sofat R, Stephens JW and Hamsten A; HIFMECH Consortium; Sanders J,
Montgomery H, et al: Association of a sequence variant in DAB2IP
with coronary heart disease. Eur Heart J. 33:881–888. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang J, Zhou HJ, Ji W and Min W:
AIP1-mediated stress signaling in atherosclerosis and
arteriosclerosis. Curr Atheroscler Rep. 17:5032015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang H, He Y, Dai S, Xu Z, Luo Y, Wan T,
Luo D, Jones D, Tang S, Chen H, et al: AIP1 functions as an
endogenous inhibitor of VEGFR2-mediated signaling and inflammatory
angiogenesis in mice. J Clin Invest. 118:3904–3916. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qiao S, Kim SH, Heck D, Goldowitz D,
LeDoux MS and Homayouni R: Dab2IP GTPase activating protein
regulates dendrite development and synapse number in cerebellum.
PLoS One. 8:e536352013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yun EJ, Baek ST, Xie D, Tseng SF, Dobin T,
Hernandez E, Zhou J, Zhang L, Yang J, Sun H, et al: DAB2IP
regulates cancer stem cell phenotypes through modulating stem cell
factor receptor and ZEB1. Oncogene. 34:2741–2752. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Thery C, Amigorena S, Raposo G and Clayton
A: Isolation and characterization of exosomes from cell culture
supernatants and biological fluids. Curr Protoc Cell Biol Chapter.
3:Unit 3.222006.
|
|
32
|
Salomon C, Ryan J, Sobrevia L, Kobayashi
M, Ashman K, Mitchell M and Rice GE: Exosomal signaling during
hypoxia mediates microvascular endothelial cell migration and
vasculogenesis. PLoS One. 8:e684512013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kobayashi M, Salomon C, Tapia J, Illanes
SE, Mitchell MD and Rice GE: Ovarian cancer cell invasiveness is
associated with discordant exosomal sequestration of Let-7 miRNA
and miR-200. J Transl Med. 12:42014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen H, Toyooka S, Gazdar AF and Hsieh JT:
Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in
prostate cancer cell lines. J Biol Chem. 278:3121–3130. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen H, Tu SW and Hsieh JT:
Down-regulation of human DAB2IP gene expression mediated by
polycomb Ezh2 compLEX and histone deacetylase in prostate cancer. J
Biol Chem. 280:22437–22444. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Duggan D, Zheng SL, Knowlton M, Benitez D,
Dimitrov L, Wiklund F, Robbins C, Isaacs SD, Cheng Y, Li G, et al:
Two genome-wide association studies of aggressive prostate cancer
implicate putative prostate tumor suppressor gene DAB2IP. J Natl
Cancer Inst. 99:1836–1844. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu K, He Q, Liao G and Han J:
Identification of critical genes and gene interaction networks that
mediate osteosarcoma metastasis to the lungs. Exp Ther Med.
10:1796–1806. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shi R, Li J, Tang F, Luo YI and Tu CQ:
Identification and functional study of osteosarcoma metastasis
marker genes. Oncol Lett. 10:1848–1852. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang L, Liu ZM, Rao YW, Cui SQ, Wang H and
Jia XJ: Downregulation of microRNA-586 inhibits proliferation,
invasion and metastasis and promotes apoptosis in human
osteosarcoma U2-OS cell line. Cytogenet Genome Res. 146:268–278.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xu J, Wan P, Wang M, Zhang J, Gao X, Hu B,
Han J, Chen L, Sun K, Wu J, et al: AIP1-mediated actin disassembly
is required for postnatal germ cell migration and spermatogonial
stem cell niche establishment. Cell Death Dis. 6:e18182015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Min J, Zaslavsky A, Fedele G, McLaughlin
SK, Reczek EE, de Raedt T, Guney I, Strochlic DE, Macconaill LE,
Beroukhim R, et al: An oncogene-tumor suppressor cascade drives
metastatic prostate cancer by coordinately activating Ras and
nuclear factor-kappaB. Nat Med. 16:286–294. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ji W, Li Y, He Y, Yin M, Zhou HJ, Boggon
TJ, Zhang H and Min W: AIP1 expression in tumor niche suppresses
tumor progression and metastasis. Cancer Res. 75:3492–3504. 2015.
View Article : Google Scholar : PubMed/NCBI
|
